Skip to content
Obsidio is now a part of Boston Scientific.
Fast Company recognizes Obsidio among 2022 honorees in Health Category of World Changing Ideas
Obsidio recognized as winner of 2021 MedTech Innovation of the Year
PM360 Magazine selects Obsidio as one of the most innovative startups of the year
Obsidio, Inc. Expands Clinical Advisory Board With Two New Members
Obsidio, Inc. Awarded Prestigious Fast Track Small Business Innovation Research Grant by National Heart, Lung, and Blood Institute
Mayo Clinic researchers develop a tissue-derived bioactive gel to stop bleeding, aid in vascular healing
Preclinical studies at Mayo Clinic demonstrate new ways to stop bleeding
Obsidio, Inc. Closes $3 Million Round, Receives Grant from The National Science Foundation and Welcomes New Board Member
Obsidio, Inc. is selected as one of the five 2020 BIO Startup Stadium Winner!